View in EDS

Assessing Safety of the Transition to Generic Imatinib in Patients with Gastrointestinal Stromal Tumours.

Saved in:
Bibliographic Details
Title: Assessing Safety of the Transition to Generic Imatinib in Patients with Gastrointestinal Stromal Tumours.
Authors: van Sabben JM; Department of Medical Oncology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066CX, Amsterdam, The Netherlands. j.v.sabben@nki.nl.; Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands. j.v.sabben@nki.nl.; Department of Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands. j.v.sabben@nki.nl., van der Kleij MBA; Department of Medical Oncology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066CX, Amsterdam, The Netherlands.; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Roets E; Department of Medical Oncology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066CX, Amsterdam, The Netherlands.; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Tissier RLM; Biostatistics Unit, The Netherlands Cancer Institute, Amsterdam, The Netherlands., van Balen DEM; Department of Pharmacy and Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Huitema ADR; Department of Pharmacy and Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Clinical Pharmacy, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.; Department of Pharmacology, Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Desar IME; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands., Reyners AKL; Department of Medical Oncology, University Medical Center Groningen, Groningen, The Netherlands., Gelderblom H; Department of Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands., Steeghs N; Department of Medical Oncology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066CX, Amsterdam, The Netherlands.; Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
Source: Oncology and therapy [Oncol Ther] 2025 Sep; Vol. 13 (3), pp. 683-694. Date of Electronic Publication: 2025 Jul 01.
Publication Type: Journal Article
Journal Info: Publisher: Adis Country of Publication: New Zealand NLM ID: 101677510 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2366-1089 (Electronic) Linking ISSN: 23661089 NLM ISO Abbreviation: Oncol Ther Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40591125
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Assessing Safety of the Transition to Generic Imatinib in Patients with Gastrointestinal Stromal Tumours.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22van+Sabben+JM%22">van Sabben JM</searchLink>; Department of Medical Oncology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066CX, Amsterdam, The Netherlands. j.v.sabben@nki.nl.; Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands. j.v.sabben@nki.nl.; Department of Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands. j.v.sabben@nki.nl.<br /><searchLink fieldCode="AU" term="%22van+der+Kleij+MBA%22">van der Kleij MBA</searchLink>; Department of Medical Oncology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066CX, Amsterdam, The Netherlands.; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Roets+E%22">Roets E</searchLink>; Department of Medical Oncology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066CX, Amsterdam, The Netherlands.; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Tissier+RLM%22">Tissier RLM</searchLink>; Biostatistics Unit, The Netherlands Cancer Institute, Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22van+Balen+DEM%22">van Balen DEM</searchLink>; Department of Pharmacy and Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Huitema+ADR%22">Huitema ADR</searchLink>; Department of Pharmacy and Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Clinical Pharmacy, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.; Department of Pharmacology, Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Desar+IME%22">Desar IME</searchLink>; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Reyners+AKL%22">Reyners AKL</searchLink>; Department of Medical Oncology, University Medical Center Groningen, Groningen, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Gelderblom+H%22">Gelderblom H</searchLink>; Department of Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Steeghs+N%22">Steeghs N</searchLink>; Department of Medical Oncology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066CX, Amsterdam, The Netherlands.; Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101677510%22">Oncology and therapy</searchLink> [Oncol Ther] 2025 Sep; Vol. 13 (3), pp. 683-694. <i>Date of Electronic Publication: </i>2025 Jul 01.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Adis%22">Adis </searchLink><i>Country of Publication: </i>New Zealand <i>NLM ID: </i>101677510 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2366-1089 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2223661089%22">23661089 </searchLink><i>NLM ISO Abbreviation: </i>Oncol Ther <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40591125
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s40487-025-00353-3
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 683
    Titles:
      – TitleFull: Assessing Safety of the Transition to Generic Imatinib in Patients with Gastrointestinal Stromal Tumours.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: van Sabben JM
      – PersonEntity:
          Name:
            NameFull: van der Kleij MBA
      – PersonEntity:
          Name:
            NameFull: Roets E
      – PersonEntity:
          Name:
            NameFull: Tissier RLM
      – PersonEntity:
          Name:
            NameFull: van Balen DEM
      – PersonEntity:
          Name:
            NameFull: Huitema ADR
      – PersonEntity:
          Name:
            NameFull: Desar IME
      – PersonEntity:
          Name:
            NameFull: Reyners AKL
      – PersonEntity:
          Name:
            NameFull: Gelderblom H
      – PersonEntity:
          Name:
            NameFull: Steeghs N
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 09
              Text: 2025 Sep
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 2366-1089
          Numbering:
            – Type: volume
              Value: 13
            – Type: issue
              Value: 3
          Titles:
            – TitleFull: Oncology and therapy
              Type: main
ResultId 1